2022 - Research.com Best Female Scientist Award
Breast cancer, Genome-wide association study, Internal medicine, Oncology and Genetics are her primary areas of study. Her Breast cancer research is multidisciplinary, relying on both Single-nucleotide polymorphism, Genotype and Genetic predisposition. Her Genome-wide association study study combines topics in areas such as Mendelian randomization, Bioinformatics, TOX3, Disease and Genetic association.
While the research belongs to areas of Internal medicine, she spends her time largely on the problem of Endocrinology, intersecting her research to questions surrounding Tamoxifen, Antiestrogen and Von Hippel–Lindau disease. Her studies deal with areas such as Odds ratio, Case-control study, Gynecology, Prostate cancer and Family history as well as Oncology. Her Genetics research incorporates elements of Cancer research and Menarche.
Her primary scientific interests are in Breast cancer, Internal medicine, Oncology, Genetics and Genome-wide association study. Her research in Breast cancer intersects with topics in Odds ratio and Single-nucleotide polymorphism, Genotype. Internal medicine and Endocrinology are commonly linked in her work.
The concepts of her Oncology study are interwoven with issues in Gynecology, Proportional hazards model, Ovarian cancer, Hazard ratio and Colorectal cancer. Hiltrud Brauch works mostly in the field of Genetics, limiting it down to concerns involving Molecular biology and, occasionally, Restriction fragment length polymorphism, Gene mapping and Chromosome. Her research integrates issues of Genetic predisposition, Bioinformatics, Quantitative trait locus, Allele and Genetic association in her study of Genome-wide association study.
Her primary areas of investigation include Breast cancer, Oncology, Internal medicine, Genome-wide association study and Estrogen receptor. The subject of her Breast cancer research is within the realm of Cancer. Her Oncology study combines topics from a wide range of disciplines, such as Odds ratio, Ovarian cancer, Single-nucleotide polymorphism, Genetic association and Prostate cancer.
The various areas that she examines in her Internal medicine study include Germline mutation and Genetic correlation. Her Genome-wide association study research is under the purview of Genetics. In Estrogen receptor, she works on issues like Genetic predisposition, which are connected to False discovery rate.
Hiltrud Brauch mainly focuses on Breast cancer, Internal medicine, Oncology, Genome-wide association study and Genetics. Breast cancer is a subfield of Cancer that Hiltrud Brauch studies. As part of her studies on Oncology, Hiltrud Brauch frequently links adjacent subjects like Germline mutation.
Her biological study spans a wide range of topics, including Genetic correlation, Allele frequency, Ovarian cancer, Epidemiology of cancer and Endometrial cancer. Her work carried out in the field of Allele frequency brings together such families of science as Single-nucleotide polymorphism, Proportional hazards model, Locus and Hazard ratio. Hiltrud Brauch has researched Odds ratio in several fields, including Cancer prevention, Genetic testing and PALB2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Nature (2007)
Mutations of the VHL tumour suppressor gene in renal carcinoma
J.R. Gnarra;K. Tory;Y. Weng;L. Schmidt.
Nature Genetics (1994)
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
L. Schmidt;F.-M. Duh;F. Chen;T. Kishida.
Nature Genetics (1997)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.
B. Zbar;H. Brauch;C. Talmadge;M. Linehan.
Nature (1987)
A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
Martin Filipits;Margaretha Rudas;Raimund Jakesz;Peter Dubsky.
Clinical Cancer Research (2011)
Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis
Benny K. Abraham;Peter Fritz;Monika McClellan;Petra Hauptvogel.
Clinical Cancer Research (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Melbourne
Cancer Council Victoria
German Cancer Research Center
German Cancer Research Center
Heidelberg University
Monash University
University of Copenhagen
Karolinska Institute
Mayo Clinic
University of Trieste
London School of Economics and Political Science
University of Iowa
Intel (United States)
Kyoto University
University of Tsukuba
National Institutes of Health
University of Córdoba
Yeditepe University
University of California, San Diego
University of Miami
University of Bordeaux
University of Western Ontario
King's College London
Queens College, CUNY
California State University, Fullerton
University of Milan